The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells
Introduction. Rearrangement of molecular pathways and activation of bypass signaling determine the progression of tumor cell resistance to various drugs. Study of the common features of resistant formation mechanisms is essential for breast and other cancer beneficial treatments.Materials and method...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-12-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/605 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849401100144214016 |
|---|---|
| author | O. E. Andreeva D. V. Sorokin S. V. Vinokurova Yu. Yu. Shchegolev N. V. Elkina A. N. Katargin R. S. Faskhutdinov D. I. Salnikova A. M. Scherbakov M. A. Krasil’nikov |
| author_facet | O. E. Andreeva D. V. Sorokin S. V. Vinokurova Yu. Yu. Shchegolev N. V. Elkina A. N. Katargin R. S. Faskhutdinov D. I. Salnikova A. M. Scherbakov M. A. Krasil’nikov |
| author_sort | O. E. Andreeva |
| collection | DOAJ |
| description | Introduction. Rearrangement of molecular pathways and activation of bypass signaling determine the progression of tumor cell resistance to various drugs. Study of the common features of resistant formation mechanisms is essential for breast and other cancer beneficial treatments.Materials and methods. The present work was performed on estrogen receptor α ERα-positive (ERα – estrogen receptor α) McF-7 breast cancer cells, established sublines resistant to the mTOR inhibitor rapamycin or antiestrogen tamoxifen, and ERα-negative MDA-MB-231 breast cancer cells. Methods used include MTT test, transient transfection, immunoblotting, real-time polymerase chain reaction and methylation analysis by bisulfite pyrosequencing.Results. We have shown that the resistance of breast cancer cells to targeted and hormonal drugs is associated with the suppression of DNA methyltransferase 3A (DNMT3A) and respective changes in DNA methylation; DNMT3A knockdown results in the partial resistance to both drugs demonstrating the pivotal role of DNMT3A suppression in the progression of cell resistance.Conclusion. Totally, the results obtained highlight the possible mechanism of tumor cell resistance to targeting/hormonal drugs based on the deregulation of DNMTs expression and demonstrate direct connection between DNMT3A suppression and resistance progression. |
| format | Article |
| id | doaj-art-e6ac69de32684d978a782743306a0325 |
| institution | Kabale University |
| issn | 2313-805X 2413-3787 |
| language | Russian |
| publishDate | 2023-12-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Успехи молекулярной онкологии |
| spelling | doaj-art-e6ac69de32684d978a782743306a03252025-08-20T03:37:50ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872023-12-0110414915610.17650/2313-805X-2023-10-4-149-156302The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cellsO. E. Andreeva0D. V. Sorokin1S. V. Vinokurova2Yu. Yu. Shchegolev3N. V. Elkina4A. N. Katargin5R. S. Faskhutdinov6D. I. Salnikova7A. M. Scherbakov8M. A. Krasil’nikov9N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; National Research Lobachevsky State University of Nizhny NovgorodN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; Gause Institute of New AntibioticsN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; National Research Lobachevsky State University of Nizhny NovgorodN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; National Research Lobachevsky State University of Nizhny NovgorodIntroduction. Rearrangement of molecular pathways and activation of bypass signaling determine the progression of tumor cell resistance to various drugs. Study of the common features of resistant formation mechanisms is essential for breast and other cancer beneficial treatments.Materials and methods. The present work was performed on estrogen receptor α ERα-positive (ERα – estrogen receptor α) McF-7 breast cancer cells, established sublines resistant to the mTOR inhibitor rapamycin or antiestrogen tamoxifen, and ERα-negative MDA-MB-231 breast cancer cells. Methods used include MTT test, transient transfection, immunoblotting, real-time polymerase chain reaction and methylation analysis by bisulfite pyrosequencing.Results. We have shown that the resistance of breast cancer cells to targeted and hormonal drugs is associated with the suppression of DNA methyltransferase 3A (DNMT3A) and respective changes in DNA methylation; DNMT3A knockdown results in the partial resistance to both drugs demonstrating the pivotal role of DNMT3A suppression in the progression of cell resistance.Conclusion. Totally, the results obtained highlight the possible mechanism of tumor cell resistance to targeting/hormonal drugs based on the deregulation of DNMTs expression and demonstrate direct connection between DNMT3A suppression and resistance progression.https://umo.abvpress.ru/jour/article/view/605rapamycintamoxifendrug resistancemcf-7 cellsprotein kinase aktdna methyltransferaseline repeats |
| spellingShingle | O. E. Andreeva D. V. Sorokin S. V. Vinokurova Yu. Yu. Shchegolev N. V. Elkina A. N. Katargin R. S. Faskhutdinov D. I. Salnikova A. M. Scherbakov M. A. Krasil’nikov The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells Успехи молекулярной онкологии rapamycin tamoxifen drug resistance mcf-7 cells protein kinase akt dna methyltransferase line repeats |
| title | The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells |
| title_full | The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells |
| title_fullStr | The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells |
| title_full_unstemmed | The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells |
| title_short | The effect of DNA methyltransferase 3A suppression in progression of the resistance phenotype in breast cancer cells |
| title_sort | effect of dna methyltransferase 3a suppression in progression of the resistance phenotype in breast cancer cells |
| topic | rapamycin tamoxifen drug resistance mcf-7 cells protein kinase akt dna methyltransferase line repeats |
| url | https://umo.abvpress.ru/jour/article/view/605 |
| work_keys_str_mv | AT oeandreeva theeffectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT dvsorokin theeffectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT svvinokurova theeffectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT yuyushchegolev theeffectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT nvelkina theeffectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT ankatargin theeffectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT rsfaskhutdinov theeffectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT disalnikova theeffectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT amscherbakov theeffectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT makrasilnikov theeffectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT oeandreeva effectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT dvsorokin effectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT svvinokurova effectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT yuyushchegolev effectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT nvelkina effectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT ankatargin effectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT rsfaskhutdinov effectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT disalnikova effectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT amscherbakov effectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells AT makrasilnikov effectofdnamethyltransferase3asuppressioninprogressionoftheresistancephenotypeinbreastcancercells |